Modrena filed a patent infringement lawsuit against Pfizer and its German partner BioNTech in the development of the first US-approved Covid...
Modrena filed a patent infringement lawsuit against Pfizer and its German partner BioNTech in the development of the first US-approved Covid-19 vaccine, alleging that Modrena's technology developed years before the global pandemic. was copied.
According to the foreign news agency "Reuters", the price of Pfizer's shares decreased by about 1%, while the price of the shares of BioNTech, listed in the United States, decreased by 1.5%, similarly, the shares of Modrena also fell by 1.7%.
Modrina said in a statement that the lawsuit for unspecified monetary damages was filed in the District Court of Massachusetts in the United States, while the lawsuit will also be filed in the Regional Court of Düsseldorf in Germany.
When contacted by Reuters, a spokesman for the Dusseldorf court said he could not confirm any such claims at this time.
Also Read: America's support for 'exemption' of patent for Corona vaccine to poor countries
"We are filing the lawsuit to protect our innovation in the mRNA technology platform, which we pioneered, investing billions of dollars in," Moderna Chief Executive Stephen Bensel said in a statement. It was patented in the current decade before the pandemic.
Modrina said her lawsuit doesn't mean people should stop getting vaccinated.
Modrina itself while Pfizer in partnership with BioNTech were the first 2 groups to develop a coronavirus vaccine.
In an emailed statement, a Pfizer spokesperson said: "Pfizer/BioNTech has not yet fully reviewed the complaint, but we are surprised by this litigation. The Covid-19 vaccine is BioNTech's proprietary MRN." A was based on technology and was developed by Pfizer and BioNTech.
Read more: America buys 100 million doses of a corona vaccine prematurely
"We are confident in the Pfizer/BioNTech vaccine intellectual property rights and will vigorously defend against the lawsuit's allegations," the spokesperson added.
BioNTech did not respond to a separate request for comment.
Massachusetts-based Modrena developed messenger RNA (mRNA) vaccine technology just over a decade ago, which allowed it to develop a Covid-19 vaccine at an unprecedented speed.
The German company BioNTech was also working on this technology in collaboration with the large American pharmaceutical company Pfizer.
The US Food and Drug Administration first approved Pfizer/BioNTech's emergency use of the Covid-19 vaccine in December 2020, followed by Modrena a week later.
Also Read: Clash in Germany and US over Corona Virus Vaccine
Modrena has generated $10.4 billion in revenue this year from the Covid-19 vaccine alone, while Pfizer has generated nearly $22 billion in vaccine revenue.
No comments
Thanks